References
- Bødker A, Andersson K-E, Batra S, Ravn Juul B, Meyhoff H-H. The distribution of estrogen receptors in the urinary tract of the male rabbit. An immunohisto-chemical and biochemical study. Scand J Urol Nephrol 1993; 27: 169–174
- Bødker A, Andersson K-E, Batra S, Ravn Juul B, Meyhoff H-H. Estrogen receptor expression in the male rabbit urethra and prostate following castration. Scand J Urol Nephrol 1994; 28: 113–118
- Bødker A, Balslev E, Ravn Juul B, et al. Estrogen receptors in the human male bladder, prostatic urethra and the prostate. Scand J Urol Nephrol 1995; 29: 161–165
- Carpenter G, Cohen S. Epidermal growth factor. Ann Rev Biochem 1979; 48: 193–216
- Cohen D W, Simak R, Fair W R, Melamed J, Scher H I, Cordon-Carlo. Expression of transforming growth fac-tor-α and the epidermal growth factor receptor in human prostate tissues. J Urol 1994; 152: 2120–2124
- Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new born animal. J Biol Chem 1962; 237: 1555–1562
- Cohen S, Carpenter G. Human epidermal growth factor: Isolation and chemical and biological properties. Proc Nat Acad Sci USA 1975; 72: 1317–1321
- Davies P, Eaton C L. Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate. Prostate 1989; 14: 123–132
- Dignass A, Holldorf A. Partial purification and characterisation of a growth factor from human hyperplastic tissues. Urol Res 1992; 20: 133–138
- Elson S D, Browne C A, Thornburn G D. Identification of epidermal growth factor-like activity in human male reproductive tissue and fluids. J Clin Endocrinol Metab 1984; 58: 589–594
- Graham C W, Lynch J H, Djakiew D. Distribution of nerve growth factor-like protein and nerve growth factor receptor inhuman benign prostatic hyperplasia and prostatic adenocarcinoma. J Urol 1992; 147: 1444–1447
- Gregory H, Willshire I R, Kavanagh J P, Blacloch N J, Chowdury S, Richards R C. Urogastrone–normal individuals and patients with benign prostatic hypertrophy. Clin Sci 1986; 70: 359–363
- Griffiths K, Akaza H, Eaton C L, . Regulation of prostatic growth. Chapter 3. Proceedings of the second international consultation on benign prostate hyperplasia (BPH), A TK Cockett, S Khoury, Y Aso, C Chatelain, K Denis, Griffiths, G Murphy, et al. 1993
- Hirata Y, Orth D N. Epidermal growth factor (Urogastrone) in human fluids: size, heterogenicity. J Clin Endoc Metab 1979; 48: 673–679
- Hollenberg M D, Gregory H. Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblasts. Life Sci 1976; 20: 267–274
- Holmquist F, Persson K, Bødker A, Andersson K-E. Some pre- and postjunctional effects of castration in rabbit isolated corpus cavernosum and urethra. J Urol 1994; 152: 1011–1016
- Ibrahim G K, Kerns B M, Macdonald J A, et al. Differential immunoreactivity of epidermal growth factor receptor in benign, hyperplastic, and malignant prostatic tissues. J Urol 1993; 149: 170–173
- Ignar-Trowbridge D M, Nelson K G, Bidwell M C, et al. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 1992; 89: 4658–4662
- James R, Bradshaw R A. Polypeptid growth factors. Ann Rev Biochem 1984; 53: 259–292
- King W J, DeSombre E R, Jensen E V, Greene G L. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res 1985; 45: 293–304
- Lingham R B, Stancel G M, Loose-Mitchel G M. Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Mol Endocrinol 1988; 2: 230–235
- Lubrano C, Sciarra F, Spera G, et al. Immunoreactive EGF in human benign prostatic hyperplasia: Relationships with androgen and estrogen receptors. J Steroid Molec Biol 1992; 41: 683–686
- Maddy S Q, Chisholm G D, Hawkins R A, Habib F K. Localisation of epidermal growth factor receptors in the human prostate by biochemical and immunohistochem-ical methods. J Endocrinol 1987; 113: 147–153
- Maddy S Q, Chisholm G D, Busuttil R A, Habib F K. Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour. Br J Cancer 1989; 60: 41–44
- Mukku V R, Stancel G M. Regulation of epidermal growth factor receptor by estrogen. J Biol Chem 1985; 260: 9820–9824
- Nelson K G, Takahashi T, Bossert N L, Walmer D K, McLachlan J A. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci USA 1991; 88: 21–25
- Schulze H, Barrack E. Immunocytochemical localisation of estrogen receptors in normal male and female canine urinary tract and prostate. Endocrinology 1987; 121: 1773–1783
- St-Arnaud R, Poyet P, Walker P, Labrie F. Androgens modulate epidermal growth factor levels in the rat ventral prostate. Mol Cell Endocrin 1988; 56: 21–27
- Story M T, Jacobs S C, Lawson R K. Epidermal growth factor is not the major growthpromoting agent in extracts of prostaic tissue. J Urol 1983; 130: 175–179
- Traish A M, Wotiz H. Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrin 1987; 121: 1461–1467
- Walsh P C, Wilson J D. The induction of prostatic hyperplasia in the dog with androstanediol. J Clin invest 1976; 57: 1093–1105
- Weaker F, Herbert F C, Sheridan P J. Autoradiographic demonstration of binding for oestradiol and dihydrotes-tosterone in the urinary tract of male and female baboons. Urol Res 1983; 11: 127–130